alteplaasi

Alteplase is a medication used to treat certain types of blood clots. It is a thrombolytic agent, meaning it works by dissolving blood clots. Alteplase is a genetically engineered version of tissue plasminogen activator (tPA), a protein naturally produced in the body that plays a role in breaking down clots. It is administered intravenously, typically in a hospital setting.

The primary uses for alteplase include the treatment of acute ischemic stroke, where it helps to restore blood flow to the brain by breaking up a clot that is blocking an artery. It is also used to treat heart attacks (myocardial infarction) by dissolving clots in the coronary arteries, and pulmonary embolism, where it breaks up clots in the lungs. The decision to use alteplase depends on factors such as the time since symptom onset and the patient's overall medical condition.

As with any medication, alteplase carries potential risks and side effects. The most significant risk is bleeding, which can occur internally or externally. Other side effects may include allergic reactions, nausea, vomiting, and changes in blood pressure. Alteplase is not suitable for all patients, and contraindications include active bleeding, recent surgery, or a history of certain types of stroke. Medical professionals carefully assess patients to determine if alteplase is an appropriate treatment option.